DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Sulodexide
Sulodexide
(12) United States Patent (10) Patent No.: US 9,498,481 B2 Rao Et Al
Characterising the Risk of Major Bleeding in Patients With
Sulodexide: Review of Recent Clinical Efficacy Data
Treatment for Superficial Thrombophlebitis of The
Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
Pharmaceutical Services Division and the Clinical Research Centre Ministry of Health Malaysia
Study Protocol
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
(19) 11 Patent Number: 6165500
Low-Molecular-Weight Heparins (LMWH) for the Treatment
Venous Thromboembolism - Management (1 of 21)
Guideline/Protocol Title: GUIDELINES for the USE of ANTITHROMBOTIC AGENTS in the SETTING of NEURAXIAL PROCEDURES
Antithrombotic Therapy in COVID-19: Systematic Summary of Ongoing Or Completed Randomized Trials
Head Injury Partial Update
(12) United States Patent (10) Patent No.: US 8,637,524 B2 Rao Et Al
Wo 2U11/132161 A2
Thrombosis and Thromboprophylaxis in COVID-19 Patients During Hospitalization and Early Post-Discharge Period
* Executive Summary
Top View
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Guidance for the Management of Patients With
Project SCYLLA
Systemic Glucocorticoids in the Treatment of COVID-19 and Risks of Adverse Outcomes in COVID-19 Patients in the Primary and Secondary Care Setting
Superior Outcomes with Argatroban for Heparin-Induced Thrombocytopenia
Effectiveness and Safety of Sulodexide in the Treatment of Venous Diseases
Pharmacological Agents Targeting Thromboinflammation in COVID-19
* Thromboembolic Disease Antithrombotic Therapy for Venous
Recent Progress and Market Analysis of Anticoagulant Drugs
Customs Tariff - Schedule Xxi - 1
Dental Considerations in Patients Taking New Antiplatelet and Anticoagulant Drugs
Sulodexide Modifies Intravascular Homeostasis What Affects Function of the Endothelium
Associated Thrombosis Covid-19
Coronavirus and Antithrombotics Search Narrative, 20 August 2020
Sulodexide in Patients with Chronic Venous Disease of the Lower Limbs: Clinical Efficacy and Impact on Quality of Life
A Rationale for the Possible Role of Heparin/Heparinoid Antithrombotics in the Management of COVID-19 Infection
Guidelines for ATC Classification and DDD Assignment 2021
A New Mechanism of Action of Sulodexide in Diabetic Nephropathy: Inhibits Heparanase-1 and Prevents FGF-2-Induced Renal Epitheli
Guidelines for ATC Classification and DDD Assignment 2011
Sulodexide and Alzheimer's Disease
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
Induced Thrombocytopenia: an Update
Harmonized Tariff Schedule of the United States (2006) (Rev
Pulmonary Thromboembolism (1 of 16)
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
Concept ID Name Class 1319998 Acebutolol Adrenergics 1154343
Agolmelatine Alogliptin Benzoate Amikacin Sulfate Apixibam
SUPPLEMENTARY MATERIAL Supplementary Appendix
MICROMEDEX® Healthcare Series Document
Identification of Potential Drug Targets Based on a Computational Biology Algorithm for Venous Thromboembolism
WO 2012/170676 Al 13 December 2012 (13.12.2012) P O P C T
Use of Sulodexide in Patients with Peripheral Vascular Disease
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
Assessment of the Risk of Hepatotoxicity with Kava Products WHO Library Cataloguing-In-Publication Data
In Vivo Antithrombotic Synergy of Oral Heparin and Arginine: Endothelial
Could Sulodexide Be Helpful in COVID-19?